Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

FOSTAMATINIB vs FRAMYCETIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

FOSTAMATINIB vs FRAMYCETIN: Safety Overview

Metric FOSTAMATINIB FRAMYCETIN
Total FAERS Reports 6,394 321
Deaths Reported 453 249
Death Rate 7.1% 77.6%
Hospitalizations 1,493 134
Average Patient Age 64.7 yrs 55.2 yrs
% Female Patients 60.8% 97.4%
FDA Approval Date Apr 17, 2018 N/A
Manufacturer Rigel Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription N/A